AGP Picks
View all

Arkansas Healthcare Report
Provided by AGP

Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 2, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
an hour ago

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Indeterminate GlobeNewswire
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
an hour ago

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

Indeterminate GlobeNewswire
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
an hour ago

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Grants of Inducement Awards
an hour ago

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
an hour ago

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026
an hour ago

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

Indeterminate GlobeNewswire
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026
an hour ago

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026

Indeterminate GlobeNewswire
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
an hour ago

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
3 hours ago

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Indeterminate GlobeNewswire
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
4 hours ago

CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative

Indeterminate GlobeNewswire
Trial Validates First Treatment to Actually Improve Alzheimer’s Disease
4 hours ago

Trial Validates First Treatment to Actually Improve Alzheimer’s Disease

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Arkansas Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.